Logomix is transforming iPSC engineering with Geno-Writing™, a groundbreaking large-scale cellular system engineering platform. Purpose-built for ex vivo applications, Geno-Writing™ enables rapid, precise, and megabase-scale modifications in human iPSCs to maximize their full therapeutic potential. We are building the foundational technology to bring innovative, scalable cell treatments to patients worldwide.
Company Details
- Employees
- 9
- Founded
- 2019
- Address
- 1030 Brittan Avenue, San Carlos,california 94070,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://logomix.bio/
- Keywords
- synthetic biology, geneediting, genomewriting, genomeengineering, cell therapy, regenerative medicine, techbio, iPSC.
- HQ
- San Carlos, California
Logomix Questions
Logomix's website is https://logomix.bio/
Logomix's LinkedIn profile is https://www.linkedin.com/company/logomixgenomics
Logomix has
9 employees.
View email and phone details for 9
employees at Logomix.
Logomix's industry is
Biotechnology Research
Logomix's top competitors are
Powerx, Inc.,
株式会社ヘリオス,
Rhinoflux Inc.,
Apogee Therapeutics,
Shinobi Therapeutics,
Logomix,
Hitech Health,
Bitbiome, Inc.,
Bluestem Biosciences, Inc.,
Hebecell Corp.
Logomix's categories are Biotechnology Research
Logomix's founding year is 2019
